Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Zeier

Showing results (291-300 of 331) with videos related to

Pageof 34
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN|May 25, 2021
Early Humoral Responses of Hemodialysis Patients after COVID-19 Vaccination with BNT162b2Claudius Speer, Daniel Göth, Louise Benning, et al.
Pharmacogenetics and Genomics|March 13, 2008
CYP3A5 genotype is not associated with a higher risk of acute rejection in tacrolimus-treated renal transplant recipientsDennis A Hesselink, Ron H N van Schaik, Madelon van Agteren, et al.
Frontiers in Immunology|October 23, 2024
Impact of deceased-donor characteristics on early graft function: outcome of kidney donor pairs accepted for transplantationChristoph F Mahler, Felix Friedl, Christian Nusshag, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|March 6, 2018
Cell cycle arrest and cell death correlate with the extent of ischaemia and reperfusion injury in patients following kidney transplantation - results of an observational pilot studyFelix C F Schmitt, Eduardo Salgado, Janina Friebe, et al.
Journal of the American Society of Nephrology : JASN|October 19, 2017
Effects of Two Immunosuppressive Treatment Protocols for IgA NephropathyThomas Rauen, Christina Fitzner, Frank Eitner, et al.
The New England Journal of Medicine|December 3, 2015
Intensive Supportive Care plus Immunosuppression in IgA NephropathyThomas Rauen, Frank Eitner, Christina Fitzner, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 13, 2017
Everolimus with cyclosporine withdrawal or low-exposure cyclosporine in kidney transplantation from Month 3: a multicentre, randomized trialKlemens Budde, Martin Zeier, Oliver Witzke, et al.
JAMA|September 10, 2009
Effects of donor pretreatment with dopamine on graft function after kidney transplantation: a randomized controlled trialPeter Schnuelle, Uwe Gottmann, Simone Hoeger, et al.
Therapeutic Drug Monitoring|July 22, 2008
AcylMPAG plasma concentrations and mycophenolic acid-related side effects in patients undergoing renal transplantation are not related to the UGT2B7-840G>A gene polymorphismMadelon van Agteren, Victor W Armstrong, Ron H N van Schaik, et al.
Frontiers in Medicine|September 5, 2022
Humoral response to SARS-CoV-2 mRNA vaccination in previous non-responder kidney transplant recipients after short-term withdrawal of mycophenolic acidLouise Benning, Christian Morath, Tessa Kühn, et al.
Pageof 34

Showing results (291-300 of 331) with videos related to

Sort By:
Pageof 34
Clinical Journal of the American Society of Nephrology : CJASN|May 25, 2021
Early Humoral Responses of Hemodialysis Patients after COVID-19 Vaccination with BNT162b2Claudius Speer, Daniel Göth, Louise Benning, et al.
Pharmacogenetics and Genomics|March 13, 2008
CYP3A5 genotype is not associated with a higher risk of acute rejection in tacrolimus-treated renal transplant recipientsDennis A Hesselink, Ron H N van Schaik, Madelon van Agteren, et al.
Frontiers in Immunology|October 23, 2024
Impact of deceased-donor characteristics on early graft function: outcome of kidney donor pairs accepted for transplantationChristoph F Mahler, Felix Friedl, Christian Nusshag, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|March 6, 2018
Cell cycle arrest and cell death correlate with the extent of ischaemia and reperfusion injury in patients following kidney transplantation - results of an observational pilot studyFelix C F Schmitt, Eduardo Salgado, Janina Friebe, et al.
Journal of the American Society of Nephrology : JASN|October 19, 2017
Effects of Two Immunosuppressive Treatment Protocols for IgA NephropathyThomas Rauen, Christina Fitzner, Frank Eitner, et al.
The New England Journal of Medicine|December 3, 2015
Intensive Supportive Care plus Immunosuppression in IgA NephropathyThomas Rauen, Frank Eitner, Christina Fitzner, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 13, 2017
Everolimus with cyclosporine withdrawal or low-exposure cyclosporine in kidney transplantation from Month 3: a multicentre, randomized trialKlemens Budde, Martin Zeier, Oliver Witzke, et al.
JAMA|September 10, 2009
Effects of donor pretreatment with dopamine on graft function after kidney transplantation: a randomized controlled trialPeter Schnuelle, Uwe Gottmann, Simone Hoeger, et al.
Therapeutic Drug Monitoring|July 22, 2008
AcylMPAG plasma concentrations and mycophenolic acid-related side effects in patients undergoing renal transplantation are not related to the UGT2B7-840G>A gene polymorphismMadelon van Agteren, Victor W Armstrong, Ron H N van Schaik, et al.
Frontiers in Medicine|September 5, 2022
Humoral response to SARS-CoV-2 mRNA vaccination in previous non-responder kidney transplant recipients after short-term withdrawal of mycophenolic acidLouise Benning, Christian Morath, Tessa Kühn, et al.
Pageof 34